ReplyCorrespondence
Dr. Carter, et al reply
JOHN D. CARTER, LOUIS R. RICCA, JOANNE VALERIANO and FRANK B. VASEY
The Journal of Rheumatology September 2009, 36 (9) 2123; DOI: https://doi.org/10.3899/jrheum.090283
JOHN D. CARTER
LOUIS R. RICCA
JOANNE VALERIANO
REFERENCES
- 1.↵
- Carter JD,
- Ladhani A,
- Ricca LR,
- Valeriano J,
- Vasey FB
- 2.↵Important changes in the CellCept (mycophenolate mofetil) prescribing information. Use of CellCept is associated with recurrent pregnancy loss and congenital malformations/change from pregnancy category C to pregnancy category D. [Internet. Accessed April 22, 2009.] Available from: http://www.fda.gov/medwAtch/SAFETY/2007/CellCept_dearhcpoct07.pdf.
- 3.↵
In this issue
The Journal of Rheumatology
Vol. 36, Issue 9
1 Sep 2009
Dr. Carter, et al reply
JOHN D. CARTER, LOUIS R. RICCA, JOANNE VALERIANO, FRANK B. VASEY
The Journal of Rheumatology Sep 2009, 36 (9) 2123; DOI: 10.3899/jrheum.090283